What are the treatments for menopause breast cancer?

Breast cancer is a major threat to women ‘ s health, and the pre-menopausal and post-menopausal cases of breast cancer are more specific.

Surgery

Surgical surgery is one of the important tools for menopause breast cancer treatment. These include, inter alia, mammography and breast-puffing. Breastectomy can be divided into whole mammography and improved root therapy. The whole mastectomy is applied in cases of multicrotomic tumours, large tumours or the patient ‘ s own wishes. The improved root therapy removes the lymphoma knot from the armpit, which is more suitable for patients at risk of transfer of lymphoma. Breastpaste is the normal tissue that removes the tumor and its surroundings, while preserving, as far as possible, the appearance of the breast. However, breast-puffing is subject to certain conditions, such as the appropriate size of the tumour to the breast ratio, the advantage of the tumour ‘ s location for the removal, the patient ‘ s willingness to breast-puff and the possibility of after-surgery. After the operation, the doctor conducts a pathological examination of the tissue to determine whether further treatment is required.

Endocrine treatment

Menopause breast cancer is mostly hormone-positive, and endocrine treatment is an important treatment. The aromatic enzyme inhibitor is a common drug that inhibits the transformation of male hormones into estrogens in post-menopausal women, thus reducing estrogen levels and inhibiting tumour cell growth. Anaconda, Icametan, etc. In addition, there are selective estrogen receptors, such as his mosaic. It competes with estrogen receptors and prevents estrogen irritation to tumor cells. For some high-risk patients, different types of endocrine therapy are likely to be used sequentially to improve treatment effectiveness. Endocrine treatment is generally provided over a long period of time and patients are required to take medication strictly in accordance with medical instructions.

chemotherapy

chemotherapy is also important in menopause breast cancer treatment, especially for patients with large tumours, transferal lymphoma lymph nodes, and high risk of relapse. Commonly used chemotherapy drugs include cystals (e.g. acinin, table acin) and vixas (e.g. vixasol, dositas). The chemotherapy programme may be single or combined. Joint chemotherapy programmes are often more effective, but the side effects may also be more significant. The chemotherapy has some adverse effects, such as nausea, vomiting, hair loss, bone marrow suppression, etc. Doctors provide appropriate support during chemotherapy to alleviate the patient ‘ s discomfort.

Let’s do it.

Treatment is mainly used after surgery, which reduces the risk of local recurrence. For those who undergo breast-puffing, the treatment is an essential part of the breast and the surrounding tissue, including armpits, areas above and below the collarbone, etc. Treatment also helps to control local tumours in cases such as mammography and lymph nodes in armpits or tumour attacks on the chest. Treatment may cause adverse reactions such as skin damage and radiopneumonia, but these side effects can be controlled to some extent as the treatment technology advances.

Target treatment

For HeR-2 positive menopausal breast cancer, the targeted treatment has had a significant impact. Curtor is a common target-oriented drug, which can be specific to Her – 2 proteins, inhibiting the growth and transfer of tumor cells. In recent years, there have also been the emergence of new target drugs or anti-pharmaceuticals (ADCs), providing more treatment options for patients.

The treatment of menopausal breast cancer requires a combination of the patient ‘ s physical condition, tumours, pathologies and molecular characteristics, and multidisciplinary teams develop individualized treatment programmes for the patient in order to improve the cure rate and the quality of life of the patient. Patients must cooperate actively in the treatment process and remain optimistic.

Breast cancer